WH
DXCM icon

Wallace Hart’s DexCom DXCM Stock Holding History

Wallace Hart’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,863
Closed -$1.38M – 49
2025
Q2 		$1.38M Buy
+15,863
New +$1.24M 1.1% 14

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wallace Hart's DXCM Position: Q3 2025 in Review

Wallace Hart sold out of DexCom (DXCM) in Q3 2025, closing a stake of 15,863 shares — an estimated $1.38M sold.

Wallace Hart first reported a position in DXCM in Q2 2025 and held it in 1 quarter. The position peaked at $1.38M in Q2 2025. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Wallace Hart reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Wallace Hart sold 15,863 DexCom shares in Q3 2025, an estimated $1.38M.
  • Wallace Hart first reported a position in DexCom in Q2 2025 and held it in 1 quarter.
  • Wallace Hart's DexCom position peaked at $1.38M in Q2 2025.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Wallace Hart's 13F filing for Q3 2025, filed 4 Nov 2025.